<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
	<channel>
		<title>Frost.com Press Releases - Healthcare</title>
		<link>http://www.frost.com/prod/servlet/press-en-releases-index.pag?mkt=HC</link>
		<description>Press Releases - Healthcare</description>
		<language>en-us</language>
		<item>
			<title>L expiration des brevets des m dicaments les plus vendus devrait avantager les g n riqueurs, selon Frost &amp; Sullivan</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252956923</link>
			<description>Le march  mondial des g n riques devrait conna tre une croissance forte dans les prochaines ann es</description>
			<pubDate>Tue, 7 Feb 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252956923</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan Honor Underlines Courtagen Life Sciences  Commitment to Innovation, which Facilitates Breakthroughs in Biomedical Research</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252616971</link>
			<description>Based on its recent analysis of the clinical diagnostic tools market, Frost &amp; Sullivan recognizes Courtagen Life Sciences, Inc. with the 2011 North American Frost &amp; Sullivan Award for New Product Innovation.</description>
			<pubDate>Thu, 2 Feb 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252616971</guid>
		</item>
		<item>
			<title>European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost &amp; Sullivan</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252516240</link>
			<description>The increasing incidence of thrombosis, paralleled by the maturing life cycles of existing products, are motivating the need for novel alternatives.</description>
			<pubDate>Wed, 1 Feb 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252516240</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan Acclaims Corden Pharma for Achieving Excellence in Product Differentiation</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252516610</link>
			<description>London, Based on its recent analysis of the pharmaceutical contract manufacturing market, Frost &amp; Sullivan recognises Corden Pharma with the 2011 Western Europe Frost &amp; Sullivan Award for Product Differentiation Excellence.</description>
			<pubDate>Wed, 1 Feb 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252516610</guid>
		</item>
		<item>
			<title>Farmaci Generici: L'Imminente Scadenza dei Brevetti per i Farmaci Pi  Venduti Beneficer  i Produttori, Secondo Frost &amp; Sullivan</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252517282</link>
			<description>Si prevede che il mercato globale dei farmaci generici assister  ad una forte crescita nei prossimi anni, dovuta alla scadenza dei brevetti per i farmaci pi  venduti ed al giudizioso impegno per il contenimento dei costi da parte dei Governi e dei fornitori di servizi sanitari in tutto il mondo.</description>
			<pubDate>Wed, 1 Feb 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252517282</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan: High Price Sensitivity in East Europe Necessitates Easier Financing Policies in the PACS Market</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252457123</link>
			<description>The East European picture archiving and communication system (PACS) market lags behind its western counterpart in size and pace. Although it is growing, most of the trends observed in the market are reminiscent of the trends in Western Europe 10 to 15 years ago.</description>
			<pubDate>Mon, 30 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252457123</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan: Wachstumsstarker Markt f r Stammzellenforschung beg nstigt Aussichten f r entsprechende Forschungswerkzeuge</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252450349</link>
			<description>Die Stammzellenforschung ist ein  u erst dynamisches Gebiet, und die diesbez glichen Forschungstrends, -schwerpunkte und -ans tze entwickeln sich extrem schnell. Der Markt f r Forschungswerkzeuge in diesem Bereich muss auf diese Herausforderungen rasch reagieren und innovative Hilfsmittel entwickeln, mit denen Forschungsleistungen unterst tzt und beschleunigt werden k nnen.</description>
			<pubDate>Mon, 30 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252450349</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan Honours Merck Serono for its Achievements in the Treatment of Infertility</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252450351</link>
			<description>Based on its recent analysis of the infertility therapeutics market, Frost &amp; Sullivan recognizes Merck Serono, the pharmaceutical division of Merck KGaA, Darmstadt, Germany, with the 2011 Europe Frost &amp; Sullivan Award for Competitive Strategy Leadership.</description>
			<pubDate>Mon, 30 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252450351</guid>
		</item>
		<item>
			<title>Cellule Staminali: Mercato Europeo degli Strumenti di Ricerca in Rapida Evoluzione, Secondo Frost &amp; Sullivan</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252049752</link>
			<description>La ricerca sulle cellule staminali   molto dinamica come conseguenza dell'evoluzione estremamente rapida delle tendenze, degli obiettivi e delle modalit  di approccio alla ricerca. Il mercato degli strumenti deve dunque adattarsi velocemente a queste sfide, sviluppando strumenti innovativi mirati in grado di accelerare i risultati delle ricerche.</description>
			<pubDate>Tue, 24 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252049752</guid>
		</item>
		<item>
			<title>Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost &amp; Sullivan</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252003643</link>
			<description>Increasingly, big pharma is viewing the outsourcing of pharmaceutical manufacturing as a strategic move that would enable them to focus on their core competencies such as R&amp;D.</description>
			<pubDate>Mon, 23 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=252003643</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan Lauds Symrise for its Unique Eyelash Enhancing Offering - SymPeptide  226 EL</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251775492</link>
			<description>The 2011 Frost &amp; Sullivan European Product Differentiation Excellence Award in the Personal Care Market is presented to Symrise for SymPeptide  226 EL. This unique product has proven its efficacy in increasing the appearance of volume, length and thickness of eyelashes.</description>
			<pubDate>Fri, 20 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251775492</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan: Bevorstehende Patenausl ufe wichtiger Blockbuster-Medikamente gewinnversprechend f r Generika-Hersteller</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251724197</link>
			<description>Aufgrund des Auslaufens der Patente wichtiger Blockbuster-Medikamente und den Bem hungen von Regierungen und Anbietern von Gesundheitsdienstleistungen</description>
			<pubDate>Thu, 19 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251724197</guid>
		</item>
		<item>
			<title>Rapidly Evolving Stem Cells Market Opens Up Doors for Related Research Tools, Says Frost &amp; Sullivan</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251617689</link>
			<description>Stem cell research is very dynamic with research trends, focus, and approaches evolving extremely rapidly. The tool market has to quickly adapt to these challenges and develop innovative tools that address and accelerate research accomplishments.</description>
			<pubDate>Wed, 18 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251617689</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan Honors QlikView Business Discovery Platform for Technology Innovation in Healthcare</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251531226</link>
			<description>Based on its recent analysis of the health data analytics market, Frost &amp; Sullivan recognizes QlikTech, Inc. with the 2011 North American Frost &amp; Sullivan Award for Technology Innovation.</description>
			<pubDate>Tue, 17 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251531226</guid>
		</item>
		<item>
			<title>Imminent Patent Expiry of Key Blockbuster Drugs to Benefit Generics Manufacturers, Anticipates Frost &amp; Sullivan</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251491675</link>
			<description>The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs and the judicious cost containment efforts of governments and healthcare service providers worldwide.</description>
			<pubDate>Mon, 16 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251491675</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan: New Testing Options Bring Prenatal Testing Market to the Forefront in the U.S. </title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251491015</link>
			<description>Prenatal testing is an available option for pregnant women around the world to obtain information at their discretion about the fetus they are carrying. Women may choose to detect chromosome abnormalities in the fetus.</description>
			<pubDate>Sat, 14 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251491015</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan: Market for NSCLC Drugs in South Korea to Grow to 54,320 Patients in 2017</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251103827</link>
			<description>Approximately 85.0 per cent of lung cancer patients in South Korea are afflicted with non-small cell lung cancer (NSCLC)</description>
			<pubDate>Thu, 12 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251103827</guid>
		</item>
		<item>
			<title>Healthcare Waste Management   Robust System required to Monitor and Treat all Medical Waste, Says Frost &amp; Sullivan</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251151330</link>
			<description>Activities by Healthcare facilities represent 3-8 percent of the climate change footprint in developed-country settings.</description>
			<pubDate>Thu, 12 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251151330</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan: Spiralling Procedures and Budgetary Pressures Motivate Uptake of Custom Procedure Trays and Packs</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251031216</link>
			<description>The highly competitive custom procedure trays and packs market is seeking to increase its profitability through the standardisation and expansion of its product offerings.</description>
			<pubDate>Tue, 10 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251031216</guid>
		</item>
		<item>
			<title>After effects of Rural-Urban Divide on the Indian Dental Market Strong, says Frost &amp; Sullivan</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251081777</link>
			<description>The healthcare industry is experiencing a quick transformation owing to the increasing demand for quality healthcare. In India, Oral healthcare is an important aspect of the overall health of an individual. Indian dental care services market, constituted by dentists and dental ancillary services, was estimated to be US $ 739 million in 2010 and is expected to reach US $ 1302.5 by 2015 at a CAGR of 12 percent.</description>
			<pubDate>Tue, 10 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=251081777</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan Applauds MDxHealth for its Proprietary Epigentic DNA-based Technology that Accelerates Cancer Diagnostic Development and Personalizes Therapeutics</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=250886934</link>
			<description>Based on its recent analysis of the molecular diagnostics for oncology market, Frost &amp; Sullivan recognizes MDxHealth with the 2011 Europe Frost &amp; Sullivan Award for Technology Leadership.</description>
			<pubDate>Mon, 9 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=250886934</guid>
		</item>
		<item>
			<title>Consumer-Driven Strategies Prove Successful in the Convoluted Remote Health Monitoring Market</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=250559742</link>
			<description>Remote monitoring remains a cornerstone for the telehealth industry. While the market contains its' fair share of challenges, the opportunity for growth in the market has never been greater.</description>
			<pubDate>Thu, 5 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=250559742</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan: Large Atrial Fibrillation Population with Unmet Needs Triggers Growth in the U.S. Anticoagulant Market</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=250559822</link>
			<description>The U.S. anticoagulant market is on the verge of a major shift in clinical practice. It is transitioning from a market dominated by a single injectable anticoagulant to a highly competitive one dominated by first-in-class novel oral anticoagulants.</description>
			<pubDate>Thu, 5 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=250559822</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan: Unlocking the Door to Mobile Health App Opportunities</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=250559977</link>
			<description>The mobile health, or mHealth, app market is playing an integral part in transforming the progressing health care IT environment.</description>
			<pubDate>Thu, 5 Jan 2012 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=250559977</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan Honors Bosch Healthcare for its Market Share Leadership of the North American Remote Patient Monitoring Market</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=249413244</link>
			<description>Based on its recent analysis of the remote patient monitoring market, Frost &amp; Sullivan recognizes Bosch Healthcare with the 2011 North American Market Share Leadership Award</description>
			<pubDate>Wed, 21 Dec 2011 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=249413244</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan: Plant Molecular Farming: a new Biotech Wave</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=249248673</link>
			<description>Currently, the two approved methods of Biopharmaceuticals manufacturing widely used in Europe are mammalian cell culture manufacturing and microbial fermentation.</description>
			<pubDate>Mon, 19 Dec 2011 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=249248673</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan Acknowledges MESA for Competitive Strategy Innovation</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=248846441</link>
			<description>Based on its recent analysis of the medical equipment maintenance services market, Frost &amp; Sullivan recognises Medical Equipment Solutions and Applications</description>
			<pubDate>Wed, 14 Dec 2011 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=248846441</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan: Hoch entwickelte Medizintechnik und medizinische Bildgebungstechnologien locken verst rkt Investoren an</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=248856793</link>
			<description>Der expandierende Marktsektor der medizinischen Bildgebungsverfahren ist durch laufend entwickelte Innovationen gekennzeichnet, und dies hat die Profite und in der Folge auch die Wachstumsraten gesteigert und dadurch vermehrt Investitionen an sich gezogen.</description>
			<pubDate>Wed, 14 Dec 2011 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=248856793</guid>
		</item>
		<item>
			<title>Key Role of Hand Hygiene in Infection Control to Spur Wider Adoption, Says Frost &amp; Sullivan</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=248856849</link>
			<description>After the booming sales of hand hygiene products in 2008 2009, volume sales plummeted in 2009 2010, before gradually recovering.</description>
			<pubDate>Wed, 14 Dec 2011 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=248856849</guid>
		</item>
		<item>
			<title>Frost &amp; Sullivan: Specialty Physicians are Poised to Embrace Biosimilars Arriving Imminently to the U.S. Market</title>
			<link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=248856966</link>
			<description>The U.S. biosimilars market is a fast approaching reality. For example, the Patient Protection and Affordable Care Act of 2010, better known as the healthcare reform introduced by President Barack Obama</description>
			<pubDate>Wed, 14 Dec 2011 00:00:00 +0000</pubDate>
			<guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=248856966</guid>
		</item>
	<script type="text/javascript">
	var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
	document.write(unescape("%3Cscript src=\'" + gaJsHost + "google-analytics.com/ga.js\' type=\'text/javascript\'%3E%3C/script%3E"));
	</script>
	<script type="text/javascript">
	var pageTracker = _gat._getTracker("UA-152389-2");
	pageTracker._initData();
	pageTracker._trackPageview();
	</script>
	</channel>
</rss>
